pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
evolocumab
Repatha (evolocumab)
Atherosclerosis
$AMGN
AMGEN INC
0
catalysts
Phase 3
evorpacept
Adenocarcinoma Of The Gastroesophageal Junction
Leukocyte surface antigen CD47
$ALXO
ALX ONCOLOGY HOLDINGS INC
0
catalysts
Preclinical
exRP-250
Psoriasis
exRNA Therapeutics Ltd
0
catalysts
← prev
page 178 of 231
next →
131
Pain
89
Neurology
1
Phase 3
exagamglogene autotemcel
Casgevy (exagamglogene autotemcel)
Beta Thalassaemia
B-cell lymphoma/leukemia 11A
$VERX
Vertex, Inc.
0
catalysts
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOX
Eloxx Pharmaceuticals, Inc.
0
catalysts
Phase 1
exarafenib
exarafenib [INN]
Melanoma
Laboratoires Pierre Fabre SA
0
catalysts
Phase 1
exenatide
Byetta (exenatide)
Type 2 Diabetes
$ORMP
ORAMED PHARMACEUTICALS INC.
0
catalysts
Phase 2
exendin-(9-39)
Hyperinsulinemia
Glucagon-like peptide 1 receptor
Children's Hospital of Philadelphia
0
catalysts
Phase 2
exeporfinium chloride
exeporfinium chloride [INN]
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infec…
AMR Bio Ltd
0
catalysts
Phase 2
ezeprogind
ezeprogind [INN]
Progressive Supranuclear Palsy
AlzProtect SAS
0
catalysts
Marketed
ezetimibe
Ezetimibe (ezetimibe)
Heterozygous Familial Hypercholesterolemia (heFH)
OEP Pharma
0
catalysts
Phase 2
ezurpimtrostat
ezurpimtrostat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Genfit SA
0
catalysts
Marketed
factor IX complex
Profilnine SD (factor IX complex)
Hemophilia B (Factor IX Deficiency)
Grifols Biologicals Inc (Inactive)
0
catalysts
Marketed
factor XIII (human)
Corifact (factor XIII (human))
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency)
CSL Behring LLC
0
catalysts
Phase 1
faldoritinib
Refractory Acute Myeloid Leukemia
$BMEA
Biomea Fusion, Inc.
0
catalysts
Marketed
famciclovir
Famciclovir (famciclovir)
Genital Herpes
Camber Pharmaceuticals Inc
0
catalysts
Marketed
famotidine
Pepcid (famotidine)
Acid Indigestion (Heartburn/Pyrosis)
$KVUE
Kenvue Inc.
0
catalysts
Phase 2
famzeretcel
famzeretcel [INN]
Retinitis Pigmentosa (Retinitis)
jCyte Inc
0
catalysts
Phase 1
farabursen sodium
Polycystic Kidney Disease
$NVS
NOVARTIS AG
0
catalysts
Phase 1
faridoxorubicin
faridoxorubicin [INN]
Dedifferentiated Liposarcoma
Avacta Life Sciences Ltd
0
catalysts
Phase 2
farletuzumab ecteribulin
Triple-Negative Breast Cancer (TNBC)
Eisai Co Ltd
0
catalysts
Phase 3
fasedienol
Aloradine (fasedienol)
Social Anxiety Disorder (SAD/Social Phobia)
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Phase 2
fasudil
BRAVYL (fasudil [INN])
Amyotrophic Lateral Sclerosis
Woolsey Pharmaceuticals Inc
0
catalysts
Phase 3
fazirsiran sodium
Alpha-1 Antitrypsin Deficiency (A1AD)
$ARWR
ARROWHEAD PHARMACEUTICALS, INC.
0
catalysts
Phase 1
fb-PMT
Recurrent Glioblastoma Multiforme (GBM)
NanoPharmaceuticals LLC
0
catalysts
Marketed
fecal microbiota, live-brpk
Vowst
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Nestle HealthCare Nutrition Inc
0
catalysts
Marketed
fecal microbiota, live-jslm
Rebyota
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Ferring Pharmaceuticals Inc
0
catalysts
Marketed
felbamate
Felbamate Wallace (felbamate)
Generalized Seizures
Wallace Pharmaceuticals Inc
0
catalysts
Marketed
felodipine ER
Felodipine (felodipine)
Hypertension
Method Pharmaceuticals LLC
0
catalysts
Phase 3
felzartamab
felzartamab [INN]
Membranous Glomerulonephritis
$BIIB
BIOGEN INC.
0
catalysts